ArticleBMC gastroenterology2026
Leptin, vitamin D, and APRI values during the six months post-liver transplantation.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLiver fibrosis is a common outcome of chronic liver disease, characterized by accumulating extracellular matrix proteins. Aims: While the gold standard in the assessment of liver fibrosis remains liver biopsy, non-invasive methods have been increasingly used for estimating liver fibrosis. This study aims at contributing to our understanding of the role of leptin,vitamin D, APRI, and FIB-4 in the progression of liver disease. For this purpose, we evaluate the clinical significance of leptin, vitamin D, APRI, and FIB-4 in cirrhotic patients with different ratios of steatosis and in cirrhotic pateints with different grades of hepatocellular carcinoma. We compare the performance of simple biochemical scores (FIB-4 and APRI) with leptin and vitamin D. Also, We identified the proteins in the serum of liver fibrosis and showed the role of these proteins in the pathogenesis of liver fibrosis. Also, we identified the relationship between leptin and vitamin D with extracellular matrix proteins using bioinformatics analysis.
methodsThe current study included 50 liver fibrosis patients who underwent liver transplantation. We measured the levels of serum vitamin D and leptin in these patients at pre-LT and three- and six-months post-LT using enzyme-linked immunosorbent assay. We performed qualitative proteomic analysis to identify the proteins in the sera from patients with liver fibrosis. Among these proteins, there are extracellular matrix proteins. One-way ANOVA test was used.
resultsWe found that serum leptin levels and APRI values were significantly higher in liver fibrosis patients than in controls, after three- and six-months following LT serum leptin levels and APRI values significantly decreased. While serum vitamin D levels were significantly lower in liver fibrosis patients than in controls, after three- and six-months following LT, serum vitamin D levels significantly increased. ROC curves analysis showed that the area under the curve (AUC) of vitamin D and leptin was 1 and 0.997, respectively. Gene ontology analysis demonstrated that the proteins participate in a diverse array of biological processes, emphasizing the systemic effects of liver fibrosis disease. From the STRING database, the proteins are at least partially biologically connected, as a group with leptin and vitamin D explaining the promiscuous nature of leptin and vitamin D. This emphasized the role of leptin and vitamin D in accumulation and increased synthesis of extracellular matrix proteins that incorporated in the pathogenesis of liver fibrosis, and showed that the leptin and vitamin D are involved in the pathogenesis process where the total proteins are involved.
conclusionsIn summary, serum vitamin D and leptin could serve as a valuable supplemental biomarker for predicting the liver fibrosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.